ANRO · NYSE
Alto Neuroscience (ANRO) Stock Price & Fundamentals
Alto Neuroscience (ANRO) closed at $322.04 on Oct 9, 2026, down 1.06% from the previous close of $325.50.
Share price, past year
1Y −5.89%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $322.04 |
| Sep 30, 2026 | $328.37 |
| Aug 31, 2026 | $321.61 |
| Jul 31, 2026 | $317.08 |
| Jun 30, 2026 | $298.23 |
| May 29, 2026 | $314.16 |
| Apr 30, 2026 | $306.61 |
| Mar 31, 2026 | $329.35 |
| Feb 27, 2026 | $347.15 |
| Jan 30, 2026 | $367.42 |
| Dec 31, 2025 | $361.06 |
| Nov 28, 2025 | $356.22 |
| Oct 31, 2025 | $347.09 |
Key statistics
- Market cap
- $11.30B
- EPS (TTM)
- −$2.43
- Net income (TTM)
- −$84.24M
- Shares outstanding
- 35.1M
- 52-week range
- $292.94 – $371.13
Alto Neuroscience's market cap is $11.30B, based on a share price of $322.04 and 35.1M shares outstanding as of Jun 30, 2026.
Financials
Alto Neuroscience's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
Alto Neuroscience reported a net loss of $63.24M in fiscal 2025.
Company profile
- Name
- Alto Neuroscience, Inc.
- Ticker
- ANRO
- Exchange
- NYSE
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 650 Castro Street, Suite 450, Mountain View, CA 94041
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001999480
Recent SEC filings
- Aug 27, 2026
- Aug 12, 2026
- Aug 12, 2026
- Jul 14, 2026
- Jul 13, 2026
- May 28, 2026
- May 13, 2026
- May 13, 2026
Frequently asked questions
What is Alto Neuroscience's stock price?
Alto Neuroscience (ANRO) closed at $322.04 on Oct 9, 2026, down 1.06% from the previous close of $325.50.
What is Alto Neuroscience's market cap?
Alto Neuroscience's market cap is $11.30B, based on a share price of $322.04 and 35.1M shares outstanding as of Jun 30, 2026.
Does Alto Neuroscience pay a dividend?
Alto Neuroscience's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Alto Neuroscience, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures